Amide compound

Details for Australian Patent Application No. 2009247262 (hide)

Owner Astellas Pharma Inc.

Inventors Watanuki, Susumu; Matsuura, Keisuke; Nozawa, Eisuke; Zenkoh, Tatsuya; Seo, Ryushi; Ikegai, Kazuhiro; Kageyama, Michihito; Ibuka, Ryotaro

Agent Pizzeys

Pub. Number AU-A-2009247262

PCT Pub. Number WO2009/139373

Priority 2008-127424 14.05.08 JP

Filing date 12 May 2009

Wipo publication date 19 November 2009

International Classifications

C07C 233/47 (2006.01) Carboxylic acid amides

A61K 31/166 (2006.01) - having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

A61K 31/195 (2006.01)

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/404 (2006.01)

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/416 (2006.01) - condensed with carbocyclic ring systems, e.g. indazole

A61K 31/4184 (2006.01)

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/423 (2006.01) - condensed with carbocyclic rings

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/428 (2006.01) - condensed with carbocyclic rings

A61K 31/437 (2006.01)

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/4412 (2006.01) - having oxo groups directly attached to the heterocyclic ring

A61K 31/4439 (2006.01)

A61K 31/454 (2006.01)

A61K 31/4545 (2006.01)

A61K 31/47 (2006.01) - Quinolines

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/4725

Event Publications

25 November 2010 PCT application entered the National Phase

  PCT publication WO2009/139373 Priority application(s): WO2009/139373

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009247267-Method for quantification of antigenspecific canine or human IgE

2009247251-Pharmaceutical preparation comprising DPP-IV inhibitor and other diabetes therapeutic agent in concomitant or combined form